Announcement
Read recent updates from the Advanced & Cell Therapies team led by Professor Fiona Thistlethwaite and about the recent appointment of Dr Emma Searle to the Haematology team within the Manchester ECMC
Read about the ACCEPT (a phase Ib/II) and ProCAID (placebo controlled randomised phase II) trials taking place at Southampton ECMC
Biospecific antibodies are showing promising activity in early phase trials in relapsed/refractory Non-Hodgkin lymphoma (NHL), including patients that have received prior CAR-T therapies.
Two trials from the Trials Acceleration Programme (TAP) will be opening across the UK - VICTOR and PROMise
Researchers in the University of Sheffield Department of Oncology and Metabolism have formed a new university spinout company (Modulus Oncology) with experienced drug development entrepreneurs Dr Clare Wareing and Dr Alan Wise from Edinburgh-based bioincubator company Cumulus Oncology.
Researchers from the University of Cambridge and Cold Spring Harbour Laboratory (CSHL) have completed an early phase clinical trial of a drug called plerixafor showing that it induces an integrated immune response in the tumours of patients with cancer types that do not usually respond to immunotherapy.
The teams from ECMC North delivered successfully their first on-line educational event on October 19th 2020. We have now moved to developing the content for the ECMC COVID-19 Community Hub, a curated on-line platform to build on the learnings from the workshops held in October.
The teams from ECMC North successfullly delivered their first online educational event on 19 October 2020. We have now moved to developing the content for the ECMC COVID-19 Community Hub, a curated online platform to build on the learnings from the workshops held in October.
Wondering what other centres do to overcome the challenges of COVID-19 for early phase trials? Interested in contributing to sharing best practice? Don’t know who to ask about COVID-19 implications when planning future trials? Then join ECMC North in the educational event to help develop a framework for delivery during the pandemic.
Below are two examples of work being done in Manchester to support the COVID effort.